Moneycontrol PRO
HomeNewsSunpharmaadvancedresearchcompany

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Sun Pharma Advance a safe bet: Tater

    Sun Pharma Advance a safe bet, says Aashish Tater, Fort Share Broking.

  • Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

  • Buy Sun Pharma Adv; target of Rs 95: Tater

    Buy Sun Pharma Adv; target of Rs 95: Tater

    Aashish Tater, Fort Share Broking is of the view that Buy Sun Pharma Advanced with a target of Rs 95.

  • Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

  • Add Sun Pharma Advanced in your portfolio: Tater

    Add Sun Pharma Advanced in your portfolio: Tater

    Add Sun Pharma Advanced in your portfolio, says Aashish Tater of Fort Share Broking.

  • Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye: 12 must-have stocks for your portfolio

    Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

  • SPARC has target of Rs 86.25: Tater

    SPARC has target of Rs 86.25: Tater

    Sun Pharma Advanced Research Company (SPARC) has target of Rs 86.25, says Ashish Tater of Fort Share Broking.

  • SPARC can test Rs 90: Tater

    SPARC can test Rs 90: Tater

    Sun Pharma Advanced Research Company (SPARC) can test Rs 90, says Ashish Tater of Fort Share Broking.

  • Bull's Eye: Stocks to buy today

    Bull's Eye: Stocks to buy today

    Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347